From: Exosome-mediated effects and applications in inflammatory diseases of the digestive system
Source | Exosomal composition | Disease | Result | The role of components in exosomes | References |
---|---|---|---|---|---|
Rat serum | Serum exosomal miR-29a-3p | Reflux esophagitis | Increased expression | A specific marker for the diagnosis of chronic RE | [40] |
Tongue-exfoliated cells | Exosomal miR-203 in tongue exfoliated cells | Gastroesophageal reflux disease | Decreased expression | A marker for the diagnosis of GERD | [41] |
HP-infected Macrophages | miR-155 in exosomes of HP-infected macrophages | Chronic gastritis caused by HP infection | Increased expression | Regulate inflammation | [43] |
Serum of patients with CAG | hsa-miR-122-5p in serum exosomes | Chronic atrophic gastritis | Increased expression | Potential biomarkers for diagnosis of CAG | [47] |
Saliva of IBD mice | salivary exosome PSMA7 | Inflammatory bowel disease | Increased expression | Important protein biomarkers for the diagnosis of IBD | [61] |
Hepatocytes | Exosomal miR-21 | Chronic hepatitis B | Decreased expression of IL-12 | Participate in virus escape | [71] |
HepAD38 cells | Proteins in exosomes: HSP60 and cell adhesion molecules | Hepatitis B | Regulation of signalling pathways | Regulate the immune response | [76] |
BMSCs | BMSC-derived exosomal miR-223 | Autoimmune hepatitis | Inhibit the expression of proinflammatory factors | Treatment | [99] |
MSCs | Klotho | Acute pancreatitis | Inhibit NF-κB signalling | Inhibit inflammation | [109] |